Prise en charge des tumeurs épithéliales thymiques

Authors: Paulus, A., Sibille, A., Bourhaba, M., Martin, M., Louis, R., Duysinx, B.

Source: Revue médicale de Liège. 70(12):623-628

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN604122415&indx=1&recIds=ETOCRN604122415

Prise en charge du cancer bronchique non à petites cellules

Authors: Sibille, A., Paulus, A., Martin, M., Bourhaba, M., Barthélemy, N., Radermecker, M., Corhay, J.-L., Louis, R., Duysinx, B.

Source: Revue médicale de Liège. 70(9):432-441

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN602826764&indx=1&recIds=ETOCRN602826764

Le cancer du sein de la femme agee

Authors: Martin, M., Collignon, J., Rorive, A., Andre, C., Bourhaba, M., Allepaerts, S., Coucke, P., Lifrange, E., Jerusalem, G.

Source: REVUE MEDICALE DE LIEGE. 66(5/6):400-408

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN294409310&indx=1&recIds=ETOCRN294409310

L'Hantavirose fait encore parler d'elle

Authors: Bourhaba, M., Giot, J. B., Tshialala, D. M., Leonard, P., Frippiat, F., Moutschen, M.

Source: REVUE MEDICALE DE LIEGE. 61(5/6):322-328

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN190893983&indx=1&recIds=ETOCRN190893983

L'image du mois. Localisation renale d'un lymphome

Authors: Dispas, H., Delperdange, M., Meunier, P., Bourhaba, M., Krzesinski, J.M.

Source: REVUE MEDICALE DE LIEGE. 65(7/8):427-429

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN277464613&indx=1&recIds=ETOCRN277464613

Doit-on encore recommander le vaccin BCG?

Authors: Collette, G., Bourhaba, M., Moutschen, M.

Source: REVUE MEDICALE DE LIEGE. 61(5/6):430-432

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN190894147&indx=1&recIds=ETOCRN190894147

PACIFIC: A Double-Blind, Placebo-Controlled Phase 3 Study of Durvalumab as Consolidation Therapy After Chemoradiation in Patients with Locally Advanced, Unresectable Non–Small Cell Lung Cancer

Authors: Antonia, S.J., Villegas, A., Daniel, D., Baz, D. Vincente, Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K.H., de Wit, M., Cho, B.C., Bourhaba, M., Quantin, X., Tokito, T., Mekhail, T., Planchard, D., Jiang, H., Huang, Y., Dennis, P.A., Özgüroğlu, M.

Source: International journal of radiation oncology, biology, physics. 99(5):1314-1315

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100061020490.0x000001&indx=1&recIds=ETOCvdc_100061020490.0x000001

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

A pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment

Authors: Moutschen, P., Bourhaba, M., Frippiat, F., Giot, J. B., Meuris, C., Leonard, P., Moutschen, M.

Source: JOURNAL OF CLINICAL VIROLOGY. 50(3):247-248

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN286894389&indx=1&recIds=ETOCRN286894389

P1.01-79 CheckMate 817: Safety of Flat-Dose Nivolumab Plus Weight-Based Ipilimumab for the First-line (1L) Treatment of Advanced NSCLC

Authors: Paz-Ares, L., Urban, L., Audigier-Valette, C., Grossi, F., Jao, K., Aucoin, J., Linardou, H., Vladimirovna Poddubskaya, E., Fischer, J., Curioni Fontecedro, A., Groen, H., Vermaelen, K., Bourhaba, M., Kowalski, D., Pillai, R., Spigel, D., Ahmed, S., Hu, W., Vickery, D., Fiore, J., Ready, N.

Source: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S493-S493

PL02.01 Overall Survival with Durvalumab Versus Placebo After Chemoradiotherapy in Stage III NSCLC: Updated Results from PACIFIC

Authors: Antonia, S., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K.H., De Wit, M., Cho, B.C., Bourhaba, M., Quantin, X., Tokito, T., Mekhail, T., Planchard, D., Kim, Y., Karapetis, C., Hiret, S., Ostoros, G., Kubota, K., Gray, J., Paz-Ares, L., De Castro Carpeño, J., Faivre-Finn, C., Reck, M., Vansteenkiste, J., Spigel, D., Wadsworth, C., Taboada, M., Dennis, P., Özgüroğlu, M.

Source: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S184-S184

403O - PACIFIC: A double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC

Authors: Murakami, S., Özgüroğlu, M., Villegas, A., Daniel, D., Baz, D.V., Hui, R., Yokoi, T., Chiappori, A., Lee, K.H., de Wit, M., Cho, B.C., Bourhaba, M., Quantin, X., Tokito, T., Mekhail, T., Planchard, D., Jiang, H., Huang, Y., Dennis, P.A., Antonia, S.J.

Source: In Annals of Oncology November 2017 28 Supplement 10:x122-x122

LBA1_PR - PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC

Authors: Paz-Ares, L., Villegas, A., Daniel, D., Baz, D.V., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K.H., de Wit, M., Cho, B.C., Bourhaba, M., Quantin, X., Tokito, T., Mekhail, T., Planchard, D., Jiang, H., Huang, Y., Dennis, P.A., Özgüroğlu, M.

Source: In Annals of Oncology September 2017 28 Supplement 5:v634-v634

This result is not displayed to guests.
Login for full access.